nodes	percent_of_prediction	percent_of_DWPC	metapath
Indapamide—KCNE1—eye—Graves' disease	0.0527	0.242	CbGeAlD
Indapamide—Aplastic anaemia—Methimazole—Graves' disease	0.0401	0.0513	CcSEcCtD
Indapamide—Vasculitis—Propylthiouracil—Graves' disease	0.0372	0.0476	CcSEcCtD
Indapamide—Aplastic anaemia—Propylthiouracil—Graves' disease	0.0341	0.0436	CcSEcCtD
Indapamide—Hepatic failure—Propylthiouracil—Graves' disease	0.0293	0.0375	CcSEcCtD
Indapamide—Dermatitis exfoliative—Propylthiouracil—Graves' disease	0.0279	0.0357	CcSEcCtD
Indapamide—Drowsiness—Methimazole—Graves' disease	0.0239	0.0305	CcSEcCtD
Indapamide—Jaundice—Methimazole—Graves' disease	0.0233	0.0298	CcSEcCtD
Indapamide—Agranulocytosis—Methimazole—Graves' disease	0.0223	0.0285	CcSEcCtD
Indapamide—Hepatitis—Methimazole—Graves' disease	0.0214	0.0274	CcSEcCtD
Indapamide—Drowsiness—Propylthiouracil—Graves' disease	0.0203	0.026	CcSEcCtD
Indapamide—Jaundice—Propylthiouracil—Graves' disease	0.0198	0.0253	CcSEcCtD
Indapamide—Agranulocytosis—Propylthiouracil—Graves' disease	0.0189	0.0242	CcSEcCtD
Indapamide—Hepatitis—Propylthiouracil—Graves' disease	0.0182	0.0233	CcSEcCtD
Indapamide—KCNQ1—pituitary gland—Graves' disease	0.018	0.0824	CbGeAlD
Indapamide—KCNQ1—adipose tissue—Graves' disease	0.0179	0.082	CbGeAlD
Indapamide—CA12—eye—Graves' disease	0.0173	0.0791	CbGeAlD
Indapamide—Vertigo—Methimazole—Graves' disease	0.0168	0.0214	CcSEcCtD
Indapamide—Leukopenia—Methimazole—Graves' disease	0.0167	0.0214	CcSEcCtD
Indapamide—CA12—connective tissue—Graves' disease	0.0166	0.0762	CbGeAlD
Indapamide—Arthralgia—Methimazole—Graves' disease	0.0159	0.0203	CcSEcCtD
Indapamide—Myalgia—Methimazole—Graves' disease	0.0159	0.0203	CcSEcCtD
Indapamide—Dysgeusia—Propylthiouracil—Graves' disease	0.0155	0.0199	CcSEcCtD
Indapamide—KCNQ1—thyroid gland—Graves' disease	0.0155	0.071	CbGeAlD
Indapamide—Oedema—Methimazole—Graves' disease	0.0152	0.0195	CcSEcCtD
Indapamide—Thrombocytopenia—Methimazole—Graves' disease	0.0149	0.0191	CcSEcCtD
Indapamide—Vertigo—Propylthiouracil—Graves' disease	0.0143	0.0182	CcSEcCtD
Indapamide—Leukopenia—Propylthiouracil—Graves' disease	0.0142	0.0182	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Methimazole—Graves' disease	0.0139	0.0177	CcSEcCtD
Indapamide—Paraesthesia—Methimazole—Graves' disease	0.0137	0.0175	CcSEcCtD
Indapamide—Somnolence—Methimazole—Graves' disease	0.0135	0.0173	CcSEcCtD
Indapamide—Myalgia—Propylthiouracil—Graves' disease	0.0135	0.0173	CcSEcCtD
Indapamide—Arthralgia—Propylthiouracil—Graves' disease	0.0135	0.0173	CcSEcCtD
Indapamide—Dyspepsia—Methimazole—Graves' disease	0.0134	0.0171	CcSEcCtD
Indapamide—Oedema—Propylthiouracil—Graves' disease	0.0129	0.0166	CcSEcCtD
Indapamide—Thrombocytopenia—Propylthiouracil—Graves' disease	0.0127	0.0162	CcSEcCtD
Indapamide—Urticaria—Methimazole—Graves' disease	0.0121	0.0155	CcSEcCtD
Indapamide—Body temperature increased—Methimazole—Graves' disease	0.012	0.0154	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Propylthiouracil—Graves' disease	0.0118	0.0151	CcSEcCtD
Indapamide—Paraesthesia—Propylthiouracil—Graves' disease	0.0116	0.0149	CcSEcCtD
Indapamide—Somnolence—Propylthiouracil—Graves' disease	0.0115	0.0147	CcSEcCtD
Indapamide—CA5B—adipose tissue—Graves' disease	0.0114	0.0525	CbGeAlD
Indapamide—Dyspepsia—Propylthiouracil—Graves' disease	0.0114	0.0146	CcSEcCtD
Indapamide—Pruritus—Methimazole—Graves' disease	0.0108	0.0138	CcSEcCtD
Indapamide—Urticaria—Propylthiouracil—Graves' disease	0.0103	0.0132	CcSEcCtD
Indapamide—Body temperature increased—Propylthiouracil—Graves' disease	0.0102	0.0131	CcSEcCtD
Indapamide—CA5B—thyroid gland—Graves' disease	0.00991	0.0454	CbGeAlD
Indapamide—Vomiting—Methimazole—Graves' disease	0.00968	0.0124	CcSEcCtD
Indapamide—Rash—Methimazole—Graves' disease	0.0096	0.0123	CcSEcCtD
Indapamide—Dermatitis—Methimazole—Graves' disease	0.00959	0.0123	CcSEcCtD
Indapamide—Headache—Methimazole—Graves' disease	0.00954	0.0122	CcSEcCtD
Indapamide—Pruritus—Propylthiouracil—Graves' disease	0.00916	0.0117	CcSEcCtD
Indapamide—Nausea—Methimazole—Graves' disease	0.00904	0.0116	CcSEcCtD
Indapamide—CA2—eye—Graves' disease	0.00886	0.0406	CbGeAlD
Indapamide—CA2—connective tissue—Graves' disease	0.00854	0.0391	CbGeAlD
Indapamide—Vomiting—Propylthiouracil—Graves' disease	0.00823	0.0105	CcSEcCtD
Indapamide—Rash—Propylthiouracil—Graves' disease	0.00816	0.0104	CcSEcCtD
Indapamide—Dermatitis—Propylthiouracil—Graves' disease	0.00816	0.0104	CcSEcCtD
Indapamide—Headache—Propylthiouracil—Graves' disease	0.00811	0.0104	CcSEcCtD
Indapamide—CA4—pituitary gland—Graves' disease	0.00794	0.0364	CbGeAlD
Indapamide—CA4—adipose tissue—Graves' disease	0.0079	0.0362	CbGeAlD
Indapamide—Nausea—Propylthiouracil—Graves' disease	0.00769	0.00984	CcSEcCtD
Indapamide—CA4—thyroid gland—Graves' disease	0.00684	0.0314	CbGeAlD
Indapamide—CA2—pituitary gland—Graves' disease	0.00658	0.0302	CbGeAlD
Indapamide—CA2—adipose tissue—Graves' disease	0.00655	0.03	CbGeAlD
Indapamide—CA2—thyroid gland—Graves' disease	0.00567	0.026	CbGeAlD
